Advertisement
Screener

Titan Pharmaceuticals, Inc. Patents: Applications Pending

Titan Pharmaceuticals, Inc. Patent Applications Pending

19 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-04-14: Application PCTUS2022071728; Invention KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS; Applicant TITAN PHARMACEUTICALS, INC.; Status PCT - International Search Report Mailed to IB.
  • 2021-06-22: Application 63213485; Invention KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS; Applicant Titan Pharmaceuticals, Inc.; Status Provisional Application Expired.
  • 2021-04-14: Application 63174958; Invention KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS; Applicant Titan Pharmaceuticals, Inc.; Status Provisional Application Expired.
  • 2019-06-25: Application PCTUS2019039072; Invention IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES; Applicant TITAN PHARMACEUTICALS, INC.; Status PCT - International Search Report Mailed to IB.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2022-04-14PCTUS2022071728KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUSTITAN PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
KATHERINE BEEBE DEVARNEY
SUNIL SREEDHARAN
RAJESH A. PATEL
MARC RUBIN
United States
United States
United States
United States
THOMAS, SHANE M
2021-06-2263213485KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUSTitan Pharmaceuticals, Inc.Provisional Application Expired
Katherine BEEBE DEVARNEY
Marc RUBIN
Rajesh A. PATEL
Sunil SREEDHARAN
United States
United States
United States
United States
2021-04-1463174958KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUSTitan Pharmaceuticals, Inc.Provisional Application Expired
Katherine BEEBE DEVARNEY
Marc RUBIN
Rajesh A. PATEL
Sunil SREEDHARAN
United States
United States
United States
United States
2019-06-25PCTUS2019039072IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCESTITAN PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
RAJESH A. PATEL
BENJAMIN FURMAN
SUNIL SREEDHARAN
United States
United States
United States
THOMAS, SHANE M
2019-06-25PCTUS2019039070LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTSTITAN PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
RAJESH A. PATEL
United States
THOMAS, SHANE M
2018-06-2562689735IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCESTitan Pharmaceuticals, Inc.Provisional Application Expired
Rajesh A. Patel
Sunil Sreedharan
Benjamin Furman
United States
United States
United States
2018-06-2562689733LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTSTitan Pharmaceuticals, Inc.Provisional Application Expired
Rajesh A. Patel
United States
2017-10-05PCTUS2017055432IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASETITAN PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
RAJESH A. PATEL
SUNIL R. BHONSLE
SUNIL SREEDHARAN
United States
United States
United States
YOUNG, LEE W
2016-10-0562404643IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASETitan Pharmaceuticals, Inc.Provisional Application Expired
Rajesh A. PATEL
Sunil SREEDHARAN
Sunil R. BHONSLE
United States
United States
United States
2011-03-16PCTUS2011028727HETEROGENEOUS IMPLANTABLE DEVICES FOR DRUG DELIVERYTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
RAJESH A. PATEL
SUNIL R. BHONSLE
United States
United States
YOUNG, LEE W
2007-05-18PCTUS2007012046IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE WITH MINIMAL INITIAL BURSTTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
LOUIS R. BUCALO
RAJESH A. PATEL
United States
United States
2007-01-30PCTUS2007002674USE OF GALLIUM TO TREAT BIOFILM- ASSOCIATED INFECTONSTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
LOUIS R. BUCALO
SUSAN SCHWENDNER
LAWERENCE R BERNSTEIN
SUNIL SREEDHARAN
UWE F. WIRTZ
United States
United States
United States
United States
United States
2006-11-07PCTUS2006043453TREATMENT AND PREVENTION OF ADVERSE LIVER CONDITIONS USING GALLIUMTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SUNIL SREEDHARAN
LOUIS R. BUCALO
LAWRENCE R. BERNSTEIN
KRISHNA P. ALLAMNENI
United States
United States
United States
United States
2005-12-09PCTUS2005044640METHODS AND COMPOSITIONS FOR INDUCTION OF TUMOR REGESSIONTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
LAUREN COSTANTINI
ANNA CASCANTE
CRISTINA FILLAT
United States
Spain
Spain
2004-12-17PCTUS2004042453USE OF GALLIUM TO TREAT INFLAMMATORY ARTHRITISTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
LOUIS, R. BUCALO
LAWRENCE R. BERNSTEIN
KRISHNA ALLAMNENI
SUNIL SREEDHARAN
United States
United States
United States
United States
2004-05-27PCTUS2004016944IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF NALMEFENETITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
RAJESH A. PATEL
LOUIS R. BUCALO
LAUREN COSANTINI
United States
United States
United States
2004-03-31PCTUS2004010270IMPLANTABLE POLYMERIC DEVIC EFOR SUSTAINED RELEASE OF DOPAMINE AGONISTTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
RAJESH A. PATEL
SOFIE KLEPPNER
LAUREN COSTANTINI
LOUIS R. BUCALO
United States
United States
United States
United States
2003-07-11PCTUS2003022181COMBINATION OF CHEMOTHERAPEUTIC DRUGS FOR INCREASE ANTITUMOR ACTIVITYTITAN PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SUNIL SREEDHARAN
LOUIS R. BUCALO
United States
United States
2003-06-02PCTUS2003017401IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINETITAN PHARMACEUTICALS, INC.PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
LOUIS R. BUCALO
RAJESH A. PATEL
United States
United States
SHEIKH, HUMERA N